Key Drivers
- Steady Profitability
- Strong Cash Flow
- Intangible-Heavy Balance
AIAI Summary
ELV is increasingly a “prove execution” story rather than a growth story: strong free cash flow, a reasonable ~13x valuation, and raised guidance support the stock, but upside now depends on management continuously offsetting weak membership and elevated medical-cost/utilization pressure with disciplined pricing, pharmacy mix, and expense control.
Price Chart
Financial Metrics
Deep Analysis
Research tool. Not personalized advice.
Fundamental Analysis
Key Financial Insights:
- •Steady Profitability
- •Strong Cash Flow
- •Intangible-Heavy Balance
ELV combines steady earnings and strong cash generation with a reasonable valuation, but thin margins, meaningful debt, and a heavy intangible asset load temper balance-sheet quality.
Price Behavior
Key Price Behavior Insights:
- •Support defended
- •Momentum improving
- •Breakout unconfirmed
Over the last month, ELV has climbed from the low $370s to around $400, with $375-$380 acting as support, but it still needs to clear $400-$401 decisively and hold above $390-$394 to confirm a stronger breakout.
Sharp swings in a few sessions show elevated short-term volatility
Sentiment & News
Key News Insights:
- •Guidance raise
- •Insider accumulation
- •Institutional support
Elevance Health delivered a Q2 beat, raised 2026 EPS guidance, and drew supportive insider and institutional buying, reinforcing a constructive post-earnings outlook.
The news is likely supportive for Elevance Health's stock, as stronger earnings, higher guidance, and positive ownership signals improve sentiment and could sustain near-term upside
Similar Companies in Healthcare
Other companies in the same sector with AI ratings